FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease

被引:73
作者
Lagerqvist, B
Diderholm, E
Lindahl, B
Husted, S
Kontny, F
Ståhle, E
Swahn, E
Venge, P
Siegbahn, A
Wallentin, L
机构
[1] Univ Uppsala Hosp, Dept Med Sci, S-75185 Uppsala, Sweden
[2] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark
[3] Univ Oslo, Ulleval Hosp, Dept Cardiol, Oslo, Norway
[4] Univ Uppsala Hosp, Dept Thorac Surg, S-75185 Uppsala, Sweden
[5] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden
关键词
D O I
10.1136/hrt.2003.031369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To develop a scoring system for risk stratification and evaluation of the effect of an early invasive strategy for treatment of unstable coronary artery disease (CAD). Design: Retrospective analysis of a randomised study (FRISC II; fast revascularisation in instability in coronary disease). Setting: 58 Scandinavian hospitals. Patients: 2457 patients with unstable CAD from the FRISC II study. Main outcome measures: One year rates of mortality and death/myocardial infarction (MI). Methods: Patients were randomly assigned to an early invasive or a non-invasive strategy. From the non-invasive invasive cohort independent variables of death or death/MI were identified. Results: Seven factors, age. 70 years, male sex, diabetes, previous MI, ST depression, and increased concentrations of troponins and markers of inflammation ( interleukin 6 or C reactive protein), were associated with an independent increased risk for death or death/MI. In patients with >= 5 of these factors the invasive strategy reduced mortality from 15.4% (20 of 130) to 5.2% (7 of 134) ( risk ratio ( RR) 0.34, 95% confidence interval (CI) 0.15 to 0.78, p = 0.006). Death/MI was also reduced in patients with 3-4 factors from 15.7% (80 of 511) to 10.8% (58 of 538) ( RR 0.69, 95% CI 0.50 to 0.94, p = 0.02). Neither death nor death/MI was reduced in patients with 0-2 risk factors. Conclusion: In unstable CAD, this scoring system based on factors independently associated with an adverse outcome can be used shortly after admission to the hospital for risk stratification and for selection of patients to an early invasive treatment strategy.
引用
收藏
页码:1047 / 1052
页数:6
相关论文
共 27 条
[1]   The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].
Antman, EM ;
Cohen, M ;
Bernink, PJLM ;
McCabe, CH ;
Horacek, T ;
Papuchis, G ;
Mautner, B ;
Corbalan, R ;
Radley, D ;
Braunwald, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842
[2]  
Austen W G, 1975, Circulation, V51, P5
[3]   Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation results from an international trial of 9461 patients [J].
Boersma, E ;
Pieper, KS ;
Steyerberg, EW ;
Wilcox, RG ;
Chang, WC ;
Lee, KL ;
Akkerhuis, KM ;
Harrington, RA ;
Deckers, JW ;
Armstrong, PW ;
Lincoff, AM ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 2000, 101 (22) :2557-2567
[4]  
CALVIN JE, 1995, JAMA-J AM MED ASSOC, V273, P136
[5]   Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Vicari, R ;
Frey, MJ ;
Lakkis, N ;
Neumann, FJ ;
Robertson, DH ;
DeLucca, PT ;
DiBattiste, PM ;
Gibson, CM ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25) :1879-1887
[6]  
Diderholm E, 2002, EUR HEART J, V23, P41, DOI 10.1053/euhj.2001.2694
[7]   The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease:: The FRISC II invasive troponin T electrocardiogram substudy [J].
Diderholm, E ;
Andrén, B ;
Frostfeldt, G ;
Genberg, M ;
Jernberg, T ;
Lagerqvist, B ;
Lindahl, B ;
Venge, P ;
Wallentin, L .
AMERICAN HEART JOURNAL, 2002, 143 (05) :760-767
[8]   Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial [J].
Fox, KAA ;
Poole-Wilson, PA ;
Henderson, RA ;
Clayton, TC ;
Chamberlain, DA ;
Shaw, TRD ;
Wheatley, DJ ;
Pocock, SJ .
LANCET, 2002, 360 (9335) :743-751
[9]   Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban [J].
Heeschen, C ;
Hamm, CW ;
Goldmann, B ;
Deu, A ;
Langenbrink, L ;
White, HD .
LANCET, 1999, 354 (9192) :1757-1762
[10]   Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis [J].
Heeschen, C ;
Hamm, CW ;
Bruemmer, J ;
Simoons, ML .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1535-1542